AI FOR MELANOMA
Helping more people survive skin cancerAI FOR MELANOMA
Helping more people survive skin cancerEvery
someone is diagnosed with melanoma
Every
someone dies from melanoma
Caught early
%
of melanoma is survivable
Working to make melanoma deaths a thing of the past
Our ambition is to help more people survive skin cancer
We can do that by using our proprietary AI technology to improve access to high quality skin cancer screening.
Watch Neil explain how we think about melanoma and where we think we can help.
Awards
Our Blogs
Hats off to the University of Heidelberg
The University of Heidelberg has published a paper in the Annals of Oncology that demonstrates the important role that artificial intelligence (AI) can play in melanoma detection. At Skin Analytics this is something that we have believed for a long time. This paper is another example of high quality research that backs us up.
read more16 Questions… A Lifesaver?
QIMR Berghofer has released an online test that helps to identify whether you are at a high risk of developing melanoma within the next 3 and a half years.A quiz may not take the place of regular skin check-ups, but it can help you find out how at risk you really are. As they say, being forewarned is being forearmed. Knowing you are in a high risk group can help motivate you to actually make that appointment to see a doctor. And with melanoma that extra time may be critical.
read moreAbout Melanoma
The Skin Analytics team explain why melanoma is so dangerous in the context of the three main types of skin cancer:
Basal cell carcinoma – a type of non-melanoma skin cancer, often appearing as a sore or shiny bump.
Squamous cell carcinoma – also a non-melanoma skin cancer, looks like a sore or wart that won’t heal.
Malignant melanoma – starts as a changing mole, and can spread very fast.
Clinically Focused Research
At Skin Analytics we understand the importance of conducting research and working with clinicians to help ensure that we can help achieve the best outcomes for skin cancer patients.
We would like to thank DermNet NZ for being a key research partner of ours.